Lv12
80 积分 2023-11-15 加入
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
1小时前
待确认
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
13小时前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
14小时前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
14小时前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
15小时前
已完结
Efficacy and adverse events of oral isotretinoin for acne: a systematic review
1个月前
已关闭
Lipoprotein(a) and ethnicities
3个月前
已完结
Prevalence of Elevated Lipoprotein(a) and its Association With Subclinical Atherosclerosis in 2.9 Million Chinese Adults
5个月前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
6个月前
已完结
皖公网安备34019202002308
